Doxycycline Hyclate Oral Capsules And Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablet/Capsules
Available Strengths: 100 mg, 200 mg
Reference Brands: Vibramycin, Monodox, Doryx(US)
Category:
Veterinary Product
Doxycycline hyclate capsules and tablets inhibit bacterial protein synthesis by binding to the 30S ribosomal subunit, preventing growth and replication. It effectively treats a wide range of bacterial infections, reduces disease spread, and supports animal health. Benefits include broad-spectrum activity, rapid action, and effectiveness against resistant strains when used as directed.
Doxycycline Hyclate Oral capsules and tablets is available in Tablet/Capsules
and strengths such as 100 mg, 200 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Doxycycline Hyclate Oral capsules and tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Doxycycline Hyclate Oral capsules and tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Doxycycline Hyclate capsules and tablets are approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP standards. In the US, FDA approval involves extensive clinical trial data and safety evaluations, while in the EU, CE marking certifies conformity with veterinary and medicinal regulations. These products undergo validation, stability testing, and rigorous audits, with detailed documentation including safety profiles, clinical trial outcomes, and manufacturing practices. For licensing procedures, approved dossiers, and latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective doxycycline formulations critical for treating bacterial infections in animals worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing